Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HU-MSCs Infusion for Refractory Connective Tissue Diseases
ChiCTR-OPB-15005956Phase 2Recruiting
- Sponsor
- Southwest Hospital of Army Medical University
- Start
- Dec 2014
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of human umbilical cord derived mesenchymal stem cells in collagenosis, rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and 5 more, sponsored by Southwest Hospital of Army Medical University. Started Dec 2014; status: recruiting.
02
Drugs
human umbilical cord derived mesenchymal stem cells
03
Conditions
collagenosisrheumatoid arthritis (RA)systemic lupus erythematosus (SLE)dermatomyositis (DM)polymyositis (PM)
Beyond the preview
Go deeper on ChiCTR-OPB-15005956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPB-15005956.